Harvey W. Smith

Cited by

	All	Since 2019
Citations	2104	864
h-index	14	13
i10-index	15	15

200

100

150

200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320248 18 30 10 20 19 19 29 65 101 139 125 139 107 119 143 130 134 184 187 177 140 41

Public access

View all

15 articles

0 articles

available

not available

Based on funding mandates

Co-authors

William J. MullerProfessor, McGill UniversityVerified email at mcgill.ca
Morag ParkProfessor of Oncology and Biochemistry, McGill University, Director Goodman Cancer Research CentreVerified email at mcgill.ca
Paul SavageGeneral Surgery Resident, University of TorontoVerified email at mail.utoronto.ca
Vincent GiguereProfessor, McGill UniversityVerified email at mcgill.ca
Guillaume BourqueProfessor, Human Genetics, McGill UniversityVerified email at mcgill.ca
Stephen McLaughlinMRC Laboratory of Molecular BiologyVerified email at mrc-lmb.cam.ac.uk
Dr S.E. JacksonUniversity of CambridgeVerified email at cam.ac.uk
Michel L. TremblayGoodman Cancer Research Centre Biochemistry McGill UniversityVerified email at mcgill.ca
Nicholas BertosResearch Associate, Goodman Cancer Research Center, McGill UniversityVerified email at mcgill.ca
Elaine NganMcGill University Goodman Cancer Research CenterVerified email at mail.mcgill.ca
Tina GruossoMcGill UniversityVerified email at mail.mcgill.ca
David P. Labbé, Ph.D., agr., chm.Associate Professor at McGill UniversityVerified email at mcgill.ca
Simon-Pierre GravelProfesseur adjoint, Faculté de pharmacie, Université de MontréalVerified email at umontreal.ca
Genevieve DebloisUniversity of Montreal, IRICVerified email at mail.mcgill.ca
Richard MarcotteNational Research Council CanadaVerified email at cnrc-nrc.gc.ca
anne-claude gingrasLunenfeld-Tanenbaum Research Institute; University of TorontoVerified email at lunenfeld.ca
Elena KuzminAssistant Professor, Concordia University; Adjunct Professor, McGill UniversityVerified email at concordia.ca
Sadiq SalehVerified email at mail.mcgill.ca
Wontae LeePh.D. candidate, McGill UniversityVerified email at mail.mcgill.ca
Christopher MoraesCanada Research Chair in Advanced Cellular Microenvironments, McGill UniversityVerified email at mcgill.ca

Harvey W. Smith

Rosalind and Morris Goodman Cancer Institute, McGill University

Verified email at mcgill.ca

breast cancer tyrosine kinase signaling epigenetics metabolism targeted therapy resistance in


Title Sort by citations Sort by year Sort by title	Cited by Cited by	Year
Regulation of cell signalling by uPAR HW Smith, CJ Marshall Nature reviews Molecular cell biology 11 (1), 23-36, 2010	1082	2010
Stimulation of the weak ATPase activity of human hsp90 by a client protein SH McLaughlin, HW Smith, SE Jackson Journal of molecular biology 315 (4), 787-798, 2002	335	2002
uPAR promotes formation of the p130Cas–Crk complex to activate Rac through DOCK180 HW Smith, P Marra, CJ Marshall The journal of cell biology 182 (4), 777-790, 2008	135	2008
ERRα mediates metabolic adaptations driving lapatinib resistance in breast cancer G Deblois, HW Smith, IS Tam, SP Gravel, M Caron, P Savage, DP Labbé, ... Nature communications 7 (1), 12156, 2016	118	2016
Targeting EZH2 reactivates a breast cancer subtype-specific anti-metastatic transcriptional program A Hirukawa, HW Smith, D Zuo, CR Dufour, P Savage, N Bertos, ... Nature communications 9 (1), 2547, 2018	79	2018
LPP is a Src substrate required for invadopodia formation and efficient breast cancer lung metastasis E Ngan, K Stoletov, HW Smith, J Common, WJ Muller, JD Lewis, ... Nature communications 8 (1), 15059, 2017	73	2017
Mammary epithelial-specific disruption of c-Src impairs cell cycle progression and tumorigenesis R Marcotte, HW Smith, V Sanguin-Gendreau, RV McDonough, WJ Muller Proceedings of the National Academy of Sciences 109 (8), 2808-2813, 2012	57	2012
KIBRA (WWC1) Is a metastasis suppressor gene affected by chromosome 5q loss in triple-negative breast cancer JF Knight, VYC Sung, E Kuzmin, AL Couzens, DA de Verteuil, ... Cell reports 22 (12), 3191-3205, 2018	47	2018
Reduction of Global H3K27me3 Enhances HER2/ErbB2 Targeted Therapy A Hirukawa, S Singh, J Wang, JP Rennhack, M Swiatnicki, ... Cell reports 29 (2), 249-257. e8, 2019	35	2019
Inducible and coupled expression of the polyomavirus middle T antigen and Cre recombinase in transgenic mice: an in vivo model for synthetic viability in … T Rao, JJ Ranger, HW Smith, SH Lam, L Chodosh, WJ Muller Breast Cancer Research 16, 1-14, 2014	35	2014
Transgenic mouse models—A seminal breakthrough in oncogene research HW Smith, WJ Muller Cold Spring Harbor Protocols 2013 (12), pdb. top069765, 2013	29	2013
An ErbB2/c-Src axis links bioenergetics with PRC2 translation to drive epigenetic reprogramming and mammary tumorigenesis HW Smith, A Hirukawa, V Sanguin-Gendreau, I Nandi, CR Dufour, D Zuo, ... Nature Communications 10 (1), 2901, 2019	27	2019
An ErbB2 splice variant lacking exon 16 drives lung carcinoma HW Smith, L Yang, C Ling, A Walsh, VD Martinez, J Boucher, D Zuo, ... Proceedings of the National Academy of Sciences 117 (33), 20139-20148, 2020	15	2020
Integration of distinct ShcA signaling complexes promotes breast tumor growth and tyrosine kinase inhibitor resistance JR Ha, R Ahn, HW Smith, V Sabourin, S Hébert, E Cepeda Cañedo, ... Molecular Cancer Research 16 (5), 894-908, 2018	14	2018
Elevated V–ATPase Activity Following PTEN Loss Is Required for Enhanced Oncogenic Signaling in Breast Cancer AH Mohammad, SH Kim, N Bertos, W El-Assaad, I Nandi, H Smith, J Yang, ... Molecular Cancer Research 18 (10), 1477-1490, 2020	11	2020
Coordinated activation of c-Src and FOXM1 drives tumor cell proliferation and breast cancer progression I Nandi, HW Smith, V Sanguin-Gendreau, L Ji, A Pacis, V Papavasiliou, ... The Journal of Clinical Investigation 133 (7), 2023	7	2023
ARF6 controls RHOB targeting to endosomes regulating cancer cell invasion K Zaoui, HW Smith, M Park, S Duhamel Molecular & Cellular Oncology 7 (5), 1766932, 2020	2	2020
Abstract B007: c-Src and PRC2 activity in ErbB2-driven mammary tumorigenesis and acquired resistance to ErbB2-targeted therapy HW Smith, A Hirukawa, V Sanguin-Gendreau, D Zuo, WJ Muller Molecular Cancer Research 11 (10_Supplement), B007-B007, 2013	2	2013
Integrated multi-omics analysis of adverse cardiac remodeling and metabolic inflexibility upon ErbB2 and ERRα deficiency CR Dufour, H Xia, W B’chir, MC Perry, U Kuzmanov, A Gainullina, ... Communications Biology 5 (1), 955, 2022	1	2022
Ezh2 promotes mammary tumor initiation through epigenetic regulation of the Wnt and mTORC1 signaling pathways L Liu, B Xiao, A Hirukawa, HW Smith, D Zuo, V Sanguin-Gendreau, ... Proceedings of the National Academy of Sciences 120 (33), e2303010120, 2023		2023

The system can't perform the operation now. Try again later.

Articles 1–20

Citations per year

Duplicate citations

Merged citations

Add co-authorsCo-authors

Follow

Cited by

Co-authors